By Karlee Weinmann ( March 25, 2014, 3:37 PM EDT) -- Health care firm Sanofi SA is in the running for Merck & Co.'s sought-after over-the-counter business, which could fetch up to $12 billion in a sale, sources told Bloomberg on Tuesday. Final bids for the unit are expected next week, with Reckitt Benckiser Group PLC the likely front-runner. The Merck unit manufactures Coppertone sunscreen and Claritin allergy medication — a key revenue driver — among countless other recognizable products. New Jersey-based Merck had previously explored swapping its over-the-counter operation with the animal health unit of Novartis AG, while Bayer AG has also expressed interest in taking it over....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.